4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-21-000270
Director sold 500 shares at an average $562.83 ($281,416)
From the SEC's structured data for this filing
Trades in this filing
FOLETTA MARK G · Director
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-01 | Sale : show line 1 in the form | −41 | $556.89 | $22,832 | 13,056 | I |
| 2021-12-01 | Sale : show line 2 in the form | −70 | $558.78 | $39,115 | 12,986 | I |
| 2021-12-01 | Sale : show line 3 in the form | −78 | $561.85 | $43,824 | 12,908 | I |
| 2021-12-01 | Sale : show line 4 in the form | −116 | $562.79 | $65,283 | 12,792 | I |
| 2021-12-01 | Sale : show line 5 in the form | −65 | $564.24 | $36,675 | 12,727 | I |
| 2021-12-01 | Sale : show line 6 in the form | −87 | $565.51 | $49,200 | 12,640 | I |
| 2021-12-01 | Sale : show line 7 in the form | −2 | $567.35 | $1,135 | 12,638 | I |
| 2021-12-01 | Sale : show line 8 in the form | −41 | $569.54 | $23,351 | 12,597 | I |
| Open-market sales · 500 sh · avg $562.83 · $281,416 | ||||||
Loading xslF345X03/edgardoc.xml…